Skip to main content

Secondary prEvention of CardiovascUlaR disease in the Elderly trial

Deliverables

Public website

Production of a public website to promote the project progress and results

Project leaflet

Document presenting the aims of SECURE and expected impact and results

SECURE poster

Document presenting the project objectives, main activities and foreseen results

SECURE recommendations - final version

Final version of the SECURE recommendations for publication

Detailed dissemination plan

Document describing all dissemination actions planned during the course of the project

Searching for OpenAIRE data...

Publications

Polypill Strategy in Secondary Cardiovascular Prevention

Author(s): Jose M Castellano, Stuart J Pocock, Deepak L Bhatt, Antonio J Quesada, Ruth Owen , Antonio Fernandez-Ortiz, Pedro L Sanchez, Francisco Marin Ortuño, Jose M Vazquez Rodriguez, Alexandra Domingo-Fernández, Iñigo Lozano, Maria C Roncaglioni, Marta Baviera, Andreana Foresta, Luisa Ojeda-Fernandez, Furio Colivicchi, Stefania A Di Fusco, Wolfram Doehner, Antje Meyer, François Schiele, Fiona Ecarnot,
Published in: New England Journal of Medicine, 00284793, 2022, ISSN 0028-4793
Publisher: Massachusetts Medical Society
DOI: 10.1056/nejmoa2208275

Barriers and Solutions to Improve Therapeutic Adherence from the Perspective of Primary Care and Hospital-Based Physicians

Author(s): Carratalá-Munuera C, Cortés-Castell E , Márquez-Contreras E , Castellano JM, Perez-Paramo M, López-Pineda A , Gil-Guillen VF
Published in: Patient Preference and Adherence, 16, 2022, ISSN 1177-889X
Publisher: Dove Medical Press Ltd
DOI: 10.2147/ppa.s319084

Putting polypills into practice: challenges and lessons learned

Author(s): Ruth Webster, Jose M Castellano, Oyere K Onuma
Published in: The Lancet, 389/10073, 2017, Page(s) 1066-1074, ISSN 0140-6736
Publisher: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(17)30558-5

Role of the polypill for secondary prevention in ischaemic heart disease

Author(s): José M Castellano, Valentín Fuster, Catriona Jennings, Eva Prescott, Héctor Bueno
Published in: European Journal of Preventive Cardiology, 24/3_suppl, 2017, Page(s) 44-51, ISSN 2047-4873
Publisher: SAGE Publications Ltd
DOI: 10.1177/2047487317707324

The cardiovascular polypill: clinical data and ongoing studies

Author(s): José M. Castellano, Héctor Bueno, Valentín Fuster
Published in: International Journal of Cardiology, 201, 2015, Page(s) S8-S14, ISSN 0167-5273
Publisher: Elsevier BV
DOI: 10.1016/S0167-5273(15)31027-5

The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention

Author(s): Juan Tamargo, José M. Castellano, Valentín Fuster
Published in: International Journal of Cardiology, 201, 2015, Page(s) S15-S23, ISSN 0167-5273
Publisher: Elsevier BV
DOI: 10.1016/S0167-5273(15)31028-7

Polypill, el policomprimido cardiovascular: del concepto a la realidad en España

Author(s): José M. Castellano, Valentín Fuster
Published in: Revista Española de Cardiología Suplementos, 15, 2015, Page(s) 19-24, ISSN 1131-3587
Publisher: Doyma
DOI: 10.1016/S1131-3587(16)30005-X

Polypill strategy at the heart of cardiovascular secondary prevention

Author(s): Borja Ibañez, José M Castellano, Valentin Fuster
Published in: Heart, 105/1, 2018, Page(s) 9-10, ISSN 1355-6037
Publisher: BMJ Publishing Group
DOI: 10.1136/heartjnl-2018-313464

Clinical Effectiveness of the Cardiovascular Polypill in a Real-Life Setting in Patients with Cardiovascular Risk: The SORS Study

Author(s): Jose M. Castellano, Juan Verdejo, Salvador Ocampo, Marco Martinez Rios, Enrique Gómez-Álvarez, Gabriela Borrayo, Emilio Ruiz, Borja Ibáñez, Valentin Fuster, Misael Arroyo, Maria Teresa Colosia, Juan E. Becerril, Roberto Vázquez, Elias Rodriguez, Alejandro Rodriguez, Rafael Márquez, Enrique Gomez, Juan M. González, Jose L. Ubiarco, Jose F. Barrera, Bertha Vitela, Laura A. Aranda, Víctor Pe
Published in: Archives of Medical Research, 01884409, 2019, Page(s) 31-40, ISSN 0188-4409
Publisher: Elsevier BV
DOI: 10.1016/j.arcmed.2019.04.001

Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials

Author(s): Buttgereit T, Palmowski A, Forsat N, Boers M, Witham MD, Rodondi N, Moutzouri E, Navidad AJQ, Van't Hof AWJ, van der Worp B, Coll-Planas L, Voshaar M, de Wit M, da Silva J, Stegemann S, Bijlsma JW, Koeller M, Mooijaart S, Kearney PM, Buttgereit F
Published in: Age and Ageing, 50(6), 2021, Page(s) 1988-1996, ISSN 0002-0729
Publisher: Oxford University Press
DOI: 10.1093/ageing/afab147

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

Author(s): Joseph P, Roshandel G, Gao P, Pais P, Lonn E, Xavier D, Avezum A, Zhu J, Liu L, Sliwa K, Gamra H, Bangdiwala SI, Teo K, Diaz R, Dans A, Lopez-Jaramillo P, Prabhakaran D, Castellano JM, Fuster V, Rodgers A, Huffman MD, Bosch J, Dagenais GR, Malekzadeh R, Yusuf S; Polypill Trialists' Collaboration.
Published in: The Lancet, 398, 2021, Page(s) 1133-146, ISSN 0140-6736
Publisher: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(21)01827-4

La polypill à travers les résultats de l'étude HOPE 3

Author(s): Mrs. Fiona Ecarnot, Prof. François Schiele
Published in: La Lettre du Cardiologue, N°505 / May 2017, 2017, Page(s) 12-16, ISSN 0761-5035
Publisher: Edimark